Larvol Delta - The-efficacy-and-safety-of-glofitamab-combined-with-polatuzumab-vedotin-in-the-treatment-of-9-cases-of-relapsedrefractory-diffuse-large-Bcell-lymphoma-after-failing-CART-cell-therapy

micvotabart pelidotin (PYX-201) - Pyxis Oncology

https://www.globenewswire.com/news-release/2026/09/08/3358096/0/en/pyxis-oncology-to-host-webcast-to-present-updated-data-from-phase-1-monotherapy-study-of-micvotabart-pelidotin-micvo-in-second-line-and-beyond-recurrent-metastatic-head-and-neck-sq.html

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next